749P Cardiotoxicity in patients treated with PARP-inhibitorsM. Blanco Clemente, C. Maximiano Alonso, M. Martínez Cutillas et al.|Annals of Oncology|2021Cited by 3
62P A multi-center real-world study of the efficacy and safety of PARP inhibitors in patients with ovarian cancer in SpainRodrigo Sánchez-Bayona, Ainhoa Madariaga, M. Simon et al.|ESMO Open|2024Cited by 0